Recently at a conference held by the Institute of Medicine (IOM), low participation in new clinical trials and research were discussed between industry professionals. One viewpoint states mistrust of clinical trials, science in general and the motives of the industry are hindering recruitment. Gaining the public’s trust and providing results could be the key to increasing participation. To read more, go here.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Imposter Participants: Fake Participants Causing Real Problems
2025 Holiday Schedule
OHRP’s Proposed Changes to the Federalwide Assurance Form: An Update
The Latest Federal Funding Cuts and Their Impact on Ethical Clinical Research Oversight
Chevron, Natural Resources Defense Council, Loper Bright Enterprises, Raimondo, et al.